Published on in Vol 9, No 2 (2022): Apr-Jun
1 Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin, Berlin, Germany
2 Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany
3 Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
4 Motognosis GmbH, Berlin, Germany
5 Department of Pediatrics, St Joseph Krankenhaus Berlin-Tempelhof, Berlin, Germany
6 Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany
7 Clinical Study Center, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany
8 Department of Neurology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany
9 Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
10 Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
11 Department of Psychiatry, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany
12 Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan
13 NeuroCure Clinical Research Center, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany
14 Department of Neurology, University of California, Irvine, CA, United States